Manufacturer record
Copmed Pharmaceuticals Pvt.Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Copmed Pharmaceuticals Pvt.Ltd (Himachal Pradesh) were declared Not of Standard Quality between September 2025 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: B7AEY043, Amoxycillin & Potassium Clavulanate Oral Suspension IP (exp Mar 2027). LUCKNOW, Uttar Pradesh (state lab) found it not of standard quality: The sample does not conforms to I.P. in respect of Content of Amoxycillin. Listed in the September 2026 alert.
Records by type
2 records linked to Copmed Pharmaceuticals Pvt.Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Amoxycillin & Potassium Clavulanate Oral Suspension IP | Batch B7AEY043Mfg Oct 2025 · Exp Mar 2027 | The sample does not conforms to I.P. in respect of Content of AmoxycillinOther | LUCKNOW, Uttar PradeshState lab | Sep 2026 |
| Ondansetron Oral Solution IP | Batch K3ADY003Mfg Apr 2025 · Exp Mar 2027 | pHpH | DCL, TelanganaState lab | Sep 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.